Welcome to
Brookstreet is an award-winning investor augmented by Brookstreet Intelligence 2.0, our AI platform. The firm was established by a select group of Shipping and principal-capital families. Our 2.0 Thesis is built on optimising the Efficiency Frontier through Diversification across Stages, Markets, Regions, and Instruments. We deploy Hybrid Growth Capital with a clear emphasis on ROCE and DPI. We invest in Artificial Intelligence (AI) innovations that deliver transformative commercial solutions in Digital Transformation, Energy Transition, Longevity, and Dual-Use Defence Technologies. Headquartered in London’s Mayfair, we operate worldwide, partnering with founders and investors across the USA, Europe, MENA, and Asia.
Swissmed Health
“We are thrilled to partner with Gottfried and Omiros of Brookstreet. This investment will enable us to take our patient care and experience to the next level.”
— George Xydas, CEO, Swissmed Health